JW Shinyak Corporation (KOSDAQ: 067290)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,665.00
-33.00 (-1.94%)
Dec 20, 2024, 9:00 AM KST
-30.90%
Market Cap 84.40B
Revenue (ttm) 101.41B
Net Income (ttm) 7.35B
Shares Out 50.69M
EPS (ttm) 144.58
PE Ratio 11.52
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 82,563
Open 1,688.00
Previous Close 1,698.00
Day's Range 1,658.00 - 1,705.00
52-Week Range 1,281.00 - 2,509.52
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 19, 2025

About JW Shinyak

JW Shinyak Corporation engages in the production, sale, and research and development of medicines and medical supplies in South Korea. It offers pharmaceutical products in the areas of dermatology, urology, pediatrics, otolaryngology, etc.; and cardiovascular, gastrointestinal, urinary, NSAIDs, antibiotics, anti-fungal, anti-viral, respiratory, antihistamines, steroid hormone, anti-obesity, and other products, as well as eye drops, and antitussives and expectorants. The company also develops prostate cancer treatment, liver cancer treatment, rh... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies
Founded 1981
Employees 197
Stock Exchange KOSDAQ
Ticker Symbol 067290
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.